Skip to main content
. 2023 Aug 21;83(21):3636–3649. doi: 10.1158/0008-5472.CAN-22-3402

Figure 4.

Figure 4. Performance evaluation of multi-msqPCR. A, Comparison between the multi-msqPCR and uniplex-msqPCR assays. The multi-msqPCR assay produced higher ΔCq values than uniplex-msqPCR assays [6.13 (ΔCq multiple hypermethylated sites) versus 1.44 (ΔCq cg11754974), 1.97 (ΔCq cg24905336), 0.47 (ΔCq cg22678228; left) and 4.43 (ΔCq multiple hypomethylated sites) versus 2.18 (ΔCq cg26026551), 1.79 (ΔCq cg00227790; right)]. B, Assessment of the analytic sensitivity of the multi-msqPCR assay. Primer probe sets for multiple hypermethylated sites (left) and multiple hypomethylated sites (right) were tested for two technical replicates with fold dilutions of 50 ng bisulfite-converted DNA. The multi-msqPCR assay detected tumor DNA signals with as little as 0.1%. ΔCq = (CqACTB− Cqbiomarker).

Performance evaluation of multi-msqPCR. A, Comparison between the multi-msqPCR and uniplex-msqPCR assays. The multi-msqPCR assay produced higher ΔCq values than uniplex-msqPCR assays [6.13 (ΔCq multiple hypermethylated sites) versus 1.44 (ΔCq cg11754974), 1.97 (ΔCq cg24905336), 0.47 (ΔCq cg22678228; left) and 4.43 (ΔCq multiple hypomethylated sites) versus 2.18 (ΔCq cg26026551), 1.79 (ΔCq cg00227790; right)]. B, Assessment of the analytic sensitivity of the multi-msqPCR assay. Primer probe sets for multiple hypermethylated sites (left) and multiple hypomethylated sites (right) were tested for two technical replicates with fold dilutions of 50 ng bisulfite-converted DNA. The multi-msqPCR assay detected tumor DNA signals with as little as 0.1%. ΔCq = (CqACTB− Cqbiomarker).